Zebra Technologies Corp: Form 10-Q for the period ended Jul 1, 2023
Filed with the SEC on Aug 1, 2023 and accepted by EDGAR at Aug 1, 2023, 16:04 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-07-01. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-04-02 to 2023-07-01 | $1.21bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2023-01-01 to 2023-07-01 | $2.62bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-04-02 to 2023-07-01 | $633.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2023-01-01 to 2023-07-01 | $1.37bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-04-02 to 2023-07-01 | $581.0m | us-gaap:GrossProfit |
| Gross profit | 6 months2023-01-01 to 2023-07-01 | $1.25bn | us-gaap:GrossProfit |
| Research and development | 3 months2023-04-02 to 2023-07-01 | $130.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2023-01-01 to 2023-07-01 | $276.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2023-04-02 to 2023-07-01 | $194.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-01-01 to 2023-07-01 | $419.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-04-02 to 2023-07-01 | $27.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-01-01 to 2023-07-01 | $62.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-04-02 to 2023-07-01 | $144.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-01-01 to 2023-07-01 | $294.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-04-02 to 2023-07-01 | $2.78 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-01-01 to 2023-07-01 | $5.68 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-04-02 to 2023-07-01 | $2.80 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-01-01 to 2023-07-01 | $5.72 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-04-02 to 2023-07-01 | 51,707,460 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-01-01 to 2023-07-01 | 51,724,026 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-01-01 to 2023-07-01 | −$110.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-01-01 to 2023-07-01 | $34.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2023-01-01 to 2023-07-01 | $52.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-07-01 | $68.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-07-01 | $1.75bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-07-01 | $7.46bn | us-gaap:Assets |
| Current liabilities | At period end2023-07-01 | $1.77bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-07-01 | $4.46bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-07-01 | $2.04bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-07-01 | $166.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2023-07-01 | $2.99bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000877212-23-000125. Last ingested by Listed: Nov 5, 2026, 17:50 ET. Listed shows no prices and gives no investment advice.